Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,000 | 1 | 53.4% |
| Food and Beverage | $870.95 | 26 | 46.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SCYNEXIS, Inc. | $1,149 | 2 | $0 (2022) |
| Dexcom, Inc. | $133.75 | 2 | $0 (2022) |
| Novo Nordisk Inc | $118.50 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $111.28 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $110.27 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.10 | 4 | $0 (2023) |
| AbbVie Inc. | $28.59 | 2 | $0 (2020) |
| Biohaven Pharmaceutical Holding Company Ltd. | $28.53 | 2 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $27.45 | 2 | $0 (2023) |
| Horizon Therapeutics plc | $24.87 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.65 | 2 | E.R. Squibb & Sons, L.L.C. ($24.79) |
| 2023 | $88.44 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($36.12) |
| 2022 | $1,408 | 12 | SCYNEXIS, Inc. ($1,149) |
| 2021 | $186.25 | 5 | DEXCOM, INC. ($112.09) |
| 2020 | $28.59 | 2 | AbbVie Inc. ($28.59) |
| 2019 | $118.50 | 1 | Novo Nordisk Inc ($118.50) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.79 | General |
| Category: Cardiovascular | ||||||
| 02/29/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 06/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: DIABETES | ||||||
| 05/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardio-renal | ||||||
| 03/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Cardio-renal | ||||||
| 01/25/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: KRYSTEXXA | ||||||
| 01/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: DIABETES | ||||||
| 10/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: PRIMARY CARE | ||||||
| 10/04/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Endocrinology | ||||||
| 08/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: DIABETES | ||||||
| 07/12/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Respiratory | ||||||
| 05/19/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/09/2022 | SCYNEXIS, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 05/09/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $149.48 | General |
| 04/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $110.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Cardiovascular | ||||||
| 03/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: Cardiovascular | ||||||
| 02/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: DIABETES | ||||||
| 01/25/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: PRIMARY CARE | ||||||
| 09/28/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: Cardiovascular | ||||||
| 09/03/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: PRIMARY CARE | ||||||
| 08/03/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: Cardiovascular | ||||||
| 07/01/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $112.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/19/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.01 | General |
| Category: Cardiovascular | ||||||
| 10/07/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 616 | 1,266 | $405,245 | $113,413 |
| 2022 | 5 | 230 | 454 | $152,365 | $38,587 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 250 | 841 | $269,120 | $78,473 | 29.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 149 | 152 | $60,800 | $13,519 | 22.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 65 | 66 | $41,250 | $9,039 | 21.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 107 | $24,075 | $6,430 | 26.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 98 | 100 | $10,000 | $5,951 | 59.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 303 | $97,040 | $24,678 | 25.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 37 | $23,125 | $5,873 | 25.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 56 | 56 | $22,400 | $4,638 | 20.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 32 | $7,200 | $1,825 | 25.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 26 | 26 | $2,600 | $1,573 | 60.5% |
About Dr. Esther Kim, DO
Dr. Esther Kim, DO is a Internal Medicine healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2019. The National Provider Identifier (NPI) number assigned to this provider is 1649835661.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Esther Kim, DO has received a total of $1,871 in payments from pharmaceutical and medical device companies, with $41.65 received in 2024. These payments were reported across 27 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($1,000).
As a Medicare-enrolled provider, Kim has provided services to 846 Medicare beneficiaries, totaling 1,720 services with total Medicare billing of $152,000. Data is available for 2 years (2022–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Henderson, NV
- Active Since 05/06/2019
- Last Updated 10/18/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649835661
Products in Payments
- Ozempic (Drug) $118.50
- DEXCOM G6 TRANSMITTER (Device) $112.09
- XARELTO (Drug) $110.27
- ELIQUIS (Drug) $100.58
- JARDIANCE (Drug) $70.10
- NURTEC ODT (Drug) $46.10
- SYNTHROID (Drug) $28.59
- Kerendia (Drug) $27.45
- KRYSTEXXA (Biological) $24.87
- CAMZYOS (Drug) $24.79
- Dexcom G6 Transmitter (Medical Supply) $21.66
- FASENRA (Biological) $19.61
- Flexitouch Plus (Device) $16.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Henderson
Ryan Hampton, D.o, D.O
Internal Medicine — Payments: $213,538
Jeffrey Levisman, M.d, M.D
Internal Medicine — Payments: $198,615
Marigene Salazar Sharma, Md, MD
Internal Medicine — Payments: $104,164
Dr. Karthiek Narala, M.d, M.D
Internal Medicine — Payments: $41,673
Sonu Bhatia, M.d, M.D
Internal Medicine — Payments: $21,843
Dr. Justin Terry, Md, MD
Internal Medicine — Payments: $21,280